Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides
- PMID: 19909897
- DOI: 10.1016/j.idc.2009.06.004
Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides
Abstract
This article reviews three classes of antibacterial agents that are uncommonly used in bacterial infections and therefore can be thought of as special-use agents. The polymyxins are reserved for gram-negative bacilli that are resistant to virtually all other classes of drugs. Rifampin is used therapeutically, occasionally as a companion drug in treatment of refractory gram-positive coccal infections, especially those involving foreign bodies. Rifaximin is a new rifamycin that is a strict enteric antibiotic approved for treatment of traveler's diarrhea and is showing promise as a possible agent for refractory Clostridium difficile infections. The aminoglycosides are used mainly as companion drugs for the treatment of resistant gram-negative bacillary infections and for gram-positive coccal endocarditis.
Republished in
-
Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides.Med Clin North Am. 2011 Jul;95(4):819-42, viii-ix. doi: 10.1016/j.mcna.2011.03.007. Med Clin North Am. 2011. PMID: 21679793
Similar articles
-
Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides.Med Clin North Am. 2011 Jul;95(4):819-42, viii-ix. doi: 10.1016/j.mcna.2011.03.007. Med Clin North Am. 2011. PMID: 21679793
-
Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides.Infect Dis Clin North Am. 2004 Sep;18(3):669-89, x. doi: 10.1016/j.idc.2004.04.007. Infect Dis Clin North Am. 2004. PMID: 15308281 Review.
-
[Aminoglycosides and polymyxins].Enferm Infecc Microbiol Clin. 2009 Mar;27(3):178-88. doi: 10.1016/j.eimc.2009.02.001. Enferm Infecc Microbiol Clin. 2009. PMID: 19303668 Review. Spanish.
-
Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.Expert Rev Anti Infect Ther. 2010 Jul;8(7):747-60. doi: 10.1586/eri.10.58. Expert Rev Anti Infect Ther. 2010. PMID: 20586560
-
Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins.J Okla State Med Assoc. 2007 Feb;100(2):60-4. J Okla State Med Assoc. 2007. PMID: 17393675 No abstract available.
Cited by
-
Natural products for the prevention of antibiotic-associated kidney injury.Curr Opin Toxicol. 2022 Dec;32:100363. doi: 10.1016/j.cotox.2022.100363. Epub 2022 Jul 20. Curr Opin Toxicol. 2022. PMID: 38884043 Free PMC article.
-
Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease.Sci Rep. 2022 Oct 14;12(1):17212. doi: 10.1038/s41598-022-21074-x. Sci Rep. 2022. PMID: 36241669 Free PMC article.
-
Increment of Lysosomal Biogenesis by Combined Extracts of Gum Arabic, Parsley, and Corn Silk: A Reparative Mechanism in Mice Renal Cells.Evid Based Complement Alternat Med. 2020 Jul 11;2020:8631258. doi: 10.1155/2020/8631258. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32733590 Free PMC article.
-
A comparison of different antibiotic regimens for the treatment of infective endocarditis.Cochrane Database Syst Rev. 2020 May 14;5(5):CD009880. doi: 10.1002/14651858.CD009880.pub3. Cochrane Database Syst Rev. 2020. PMID: 32407558 Free PMC article.
-
The Supramolecular Self-Assembly of Aminoglycoside Antibiotics and their Applications.ChemistryOpen. 2019 Aug 26;8(9):1154-1166. doi: 10.1002/open.201900193. eCollection 2019 Sep. ChemistryOpen. 2019. PMID: 31497469 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
